Armata Pharmaceuticals, Inc. Logo

Armata Pharmaceuticals, Inc.

Develops bacteriophage therapeutics for antibiotic-resistant bacterial infections.

ARMP | US

Overview

Corporate Details

ISIN(s):
US04216R1023
LEI:
Country:
United States of America
Address:
5005 MCCONNELL AVE, 90066 LOS ANGELES

Description

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company's core focus is on creating precisely targeted, high-purity phage-based treatments for serious bacterial infections. This approach aims to provide an effective alternative to conventional antibiotics by eliminating harmful bacteria while preserving the patient's healthy microbiome. Armata's pipeline includes product candidates targeting multi-drug resistant pathogens, supported by its in-house cGMP manufacturing facility for clinical and commercial supply.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-01 18:17
FORM 8-K
English ZIP 271.6 KB
2025-12-01 18:15
424B5
English ZIP 243.9 KB
2025-11-12 17:16
10-Q
English ZIP 1.5 MB
2025-11-12 17:10
8-K
English ZIP 111.9 KB
2025-10-22 13:15
FORM 8-K
English ZIP 5.5 MB
2025-09-10 20:15
FORM 8-K
English ZIP 17.4 MB
2025-08-25 02:15 English ZIP 5.3 KB
2025-08-20 18:06 English ZIP 30.1 KB
2025-08-15 16:36 English ZIP 57.9 KB
2025-08-13 19:16
FORM S-8
English ZIP 84.7 KB
2025-08-13 19:15
FORM S-3
English ZIP 340.2 KB
2025-08-12 23:38 English ZIP 10.6 KB
2025-08-12 18:36
10-Q
English ZIP 1.5 MB
2025-08-12 18:16
8-K
English ZIP 401.2 KB
2025-07-14 18:05
OWNERSHIP DOCUMENT
English ZIP 7.1 KB

Automate Your Workflow. Get a real-time feed of all Armata Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Armata Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Armata Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.